Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain

Suresh Kumar Swaminathan, Kristen M. Ahlschwede, Vidur Sarma, Geoffry L. Curran, Rajesh S. Omtri, Teresa Decklever, Val Lowe, Joseph F. Poduslo, Karunya K. Kandimalla

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Impaired brain clearance of amyloid-beta peptides (Aβ) 40 and 42 across the blood–brain barrier (BBB) is believed to be one of the pathways responsible for Alzheimer’s disease (AD) pathogenesis. Hyperinsulinemia prevalent in type II diabetes was shown to damage cerebral vasculature and increase Aβ accumulation in AD brain. However, there is no clarity on how aberrations in peripheral insulin levels affect Aβ accumulation in the brain. This study describes, for the first time, an intricate relation between plasma insulin and Aβ transport at the BBB. Upon peripheral insulin administration in wild-type mice: the plasma clearance of Aβ40 increased, but Aβ42 clearance reduced; the plasma-to-brain influx of Aβ40 increased, and that of Aβ42 reduced; and the clearance of intracerebrally injected Aβ40 decreased, whereas Aβ42 clearance increased. In hCMEC/D3 monolayers (in vitro BBB model) exposed to insulin, the luminal uptake and luminal-to-abluminal permeability of Aβ40 increased and that of Aβ42 reduced; the abluminal-to-luminal permeability of Aβ40 decreased, whereas Aβ42 permeability increased. Moreover, Aβ cellular trafficking machinery was altered. In summary, Aβ40 and Aβ42 demonstrated distinct distribution kinetics in plasma and brain compartments, and insulin differentially modulated their distribution. Cerebrovascular disease and metabolic disorders may disrupt this intricate homeostasis and aggravate AD pathology.

Original languageEnglish (US)
JournalJournal of Cerebral Blood Flow and Metabolism
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

Amyloid
Insulin
Brain
Permeability
Alzheimer Disease
Cerebrovascular Disorders
Amyloid beta-Peptides
Hyperinsulinism
Type 2 Diabetes Mellitus
Homeostasis
Pathology

Keywords

  • Alzheimer's disease
  • blood–brain barrier
  • cerebrovascular disease
  • diabetes
  • endothelium
  • insulin
  • pharmacokinetics
  • SPECT

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Swaminathan, S. K., Ahlschwede, K. M., Sarma, V., Curran, G. L., Omtri, R. S., Decklever, T., ... Kandimalla, K. K. (Accepted/In press). Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain. Journal of Cerebral Blood Flow and Metabolism. https://doi.org/10.1177/0271678X17709709

Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain. / Swaminathan, Suresh Kumar; Ahlschwede, Kristen M.; Sarma, Vidur; Curran, Geoffry L.; Omtri, Rajesh S.; Decklever, Teresa; Lowe, Val; Poduslo, Joseph F.; Kandimalla, Karunya K.

In: Journal of Cerebral Blood Flow and Metabolism, 01.01.2017.

Research output: Contribution to journalArticle

Swaminathan, Suresh Kumar ; Ahlschwede, Kristen M. ; Sarma, Vidur ; Curran, Geoffry L. ; Omtri, Rajesh S. ; Decklever, Teresa ; Lowe, Val ; Poduslo, Joseph F. ; Kandimalla, Karunya K. / Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain. In: Journal of Cerebral Blood Flow and Metabolism. 2017.
@article{c5017217215844c8906b629f70270223,
title = "Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain",
abstract = "Impaired brain clearance of amyloid-beta peptides (Aβ) 40 and 42 across the blood–brain barrier (BBB) is believed to be one of the pathways responsible for Alzheimer’s disease (AD) pathogenesis. Hyperinsulinemia prevalent in type II diabetes was shown to damage cerebral vasculature and increase Aβ accumulation in AD brain. However, there is no clarity on how aberrations in peripheral insulin levels affect Aβ accumulation in the brain. This study describes, for the first time, an intricate relation between plasma insulin and Aβ transport at the BBB. Upon peripheral insulin administration in wild-type mice: the plasma clearance of Aβ40 increased, but Aβ42 clearance reduced; the plasma-to-brain influx of Aβ40 increased, and that of Aβ42 reduced; and the clearance of intracerebrally injected Aβ40 decreased, whereas Aβ42 clearance increased. In hCMEC/D3 monolayers (in vitro BBB model) exposed to insulin, the luminal uptake and luminal-to-abluminal permeability of Aβ40 increased and that of Aβ42 reduced; the abluminal-to-luminal permeability of Aβ40 decreased, whereas Aβ42 permeability increased. Moreover, Aβ cellular trafficking machinery was altered. In summary, Aβ40 and Aβ42 demonstrated distinct distribution kinetics in plasma and brain compartments, and insulin differentially modulated their distribution. Cerebrovascular disease and metabolic disorders may disrupt this intricate homeostasis and aggravate AD pathology.",
keywords = "Alzheimer's disease, blood–brain barrier, cerebrovascular disease, diabetes, endothelium, insulin, pharmacokinetics, SPECT",
author = "Swaminathan, {Suresh Kumar} and Ahlschwede, {Kristen M.} and Vidur Sarma and Curran, {Geoffry L.} and Omtri, {Rajesh S.} and Teresa Decklever and Val Lowe and Poduslo, {Joseph F.} and Kandimalla, {Karunya K.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1177/0271678X17709709",
language = "English (US)",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain

AU - Swaminathan, Suresh Kumar

AU - Ahlschwede, Kristen M.

AU - Sarma, Vidur

AU - Curran, Geoffry L.

AU - Omtri, Rajesh S.

AU - Decklever, Teresa

AU - Lowe, Val

AU - Poduslo, Joseph F.

AU - Kandimalla, Karunya K.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Impaired brain clearance of amyloid-beta peptides (Aβ) 40 and 42 across the blood–brain barrier (BBB) is believed to be one of the pathways responsible for Alzheimer’s disease (AD) pathogenesis. Hyperinsulinemia prevalent in type II diabetes was shown to damage cerebral vasculature and increase Aβ accumulation in AD brain. However, there is no clarity on how aberrations in peripheral insulin levels affect Aβ accumulation in the brain. This study describes, for the first time, an intricate relation between plasma insulin and Aβ transport at the BBB. Upon peripheral insulin administration in wild-type mice: the plasma clearance of Aβ40 increased, but Aβ42 clearance reduced; the plasma-to-brain influx of Aβ40 increased, and that of Aβ42 reduced; and the clearance of intracerebrally injected Aβ40 decreased, whereas Aβ42 clearance increased. In hCMEC/D3 monolayers (in vitro BBB model) exposed to insulin, the luminal uptake and luminal-to-abluminal permeability of Aβ40 increased and that of Aβ42 reduced; the abluminal-to-luminal permeability of Aβ40 decreased, whereas Aβ42 permeability increased. Moreover, Aβ cellular trafficking machinery was altered. In summary, Aβ40 and Aβ42 demonstrated distinct distribution kinetics in plasma and brain compartments, and insulin differentially modulated their distribution. Cerebrovascular disease and metabolic disorders may disrupt this intricate homeostasis and aggravate AD pathology.

AB - Impaired brain clearance of amyloid-beta peptides (Aβ) 40 and 42 across the blood–brain barrier (BBB) is believed to be one of the pathways responsible for Alzheimer’s disease (AD) pathogenesis. Hyperinsulinemia prevalent in type II diabetes was shown to damage cerebral vasculature and increase Aβ accumulation in AD brain. However, there is no clarity on how aberrations in peripheral insulin levels affect Aβ accumulation in the brain. This study describes, for the first time, an intricate relation between plasma insulin and Aβ transport at the BBB. Upon peripheral insulin administration in wild-type mice: the plasma clearance of Aβ40 increased, but Aβ42 clearance reduced; the plasma-to-brain influx of Aβ40 increased, and that of Aβ42 reduced; and the clearance of intracerebrally injected Aβ40 decreased, whereas Aβ42 clearance increased. In hCMEC/D3 monolayers (in vitro BBB model) exposed to insulin, the luminal uptake and luminal-to-abluminal permeability of Aβ40 increased and that of Aβ42 reduced; the abluminal-to-luminal permeability of Aβ40 decreased, whereas Aβ42 permeability increased. Moreover, Aβ cellular trafficking machinery was altered. In summary, Aβ40 and Aβ42 demonstrated distinct distribution kinetics in plasma and brain compartments, and insulin differentially modulated their distribution. Cerebrovascular disease and metabolic disorders may disrupt this intricate homeostasis and aggravate AD pathology.

KW - Alzheimer's disease

KW - blood–brain barrier

KW - cerebrovascular disease

KW - diabetes

KW - endothelium

KW - insulin

KW - pharmacokinetics

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=85040650799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040650799&partnerID=8YFLogxK

U2 - 10.1177/0271678X17709709

DO - 10.1177/0271678X17709709

M3 - Article

C2 - 28569090

AN - SCOPUS:85040650799

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

ER -